ADUS

Addus HomeCare Corporation

Price

$120.02

return (12m)

3.75%

p/e

20.98

p/bv

1.92

DIVIDEND YIELD

0.00%

ADUS price

Addus HomeCare

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ADUS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.87%

3 months

28.69%

1 year

3.75%

2 years

-9.11%

5 years

37.06%

10 years

454.62%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ADUS

Valuation

P/E

20.98

Sector -2.19

Industry 1.21

P/BV

1.92

Sector 2.22

Industry 2.11

P/Revenue (PSR)

1.50

Sector 2.01

Industry 0.78

EV/EBITDA

50.41

Sector -17.81

Industry -25.30

EV/EBIT

55.75

Sector -26.72

Industry -18.04

P/EBITDA

13.28

Sector 0.36

Industry 0.18

P/EBIT

14.77

Sector -3.34

Industry 1.26

P/Total Assets

1.52

Sector 1.23

Industry 0.86

P/Net Current Assets

-91.35

Sector -27.35

Industry -12.37

P/Working Capital

19.04

Sector -4.54

Industry -49.48

EPS

5.54

Sector -0.87

Industry -0.55

BVPS

60.43

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

32.36%

Sector 43.36%

Industry 31.53%

EBITDA Margin

11.41%

Sector -323.65%

Industry -73.39%

EBIT Margin

10.32%

Sector -194.57%

Industry -11.94%

Operating Margin

10.04%

Sector -24.37%

Industry -9.87%

Net Profit Margins

7.13%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.26

Sector 0.12

Industry 0.22

Profitability

ROE

9.17%

Sector -33.82%

Industry -37.56%

ROA

7.23%

Sector -29.63%

Industry -17.56%

ROIC

9.29%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.69

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-0.88

Sector -1.47

Industry -31.86

Net Debt / EBIT

-0.98

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.03

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.05

Sector 0.14

Industry 0.51

Equity/Assets

0.79

Sector 0.42

Industry 0.25

Liabilities/Assets

0.21

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

11.30%

Sector -

Industry -

5Y Earnings CAGR

18.47%

Sector -

Industry -

FAIR VALUE OF Addus HomeCare ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$120.02

Fair Value

$86.79

Upside Return potential.

-27.69%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ADUS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ADUS Addus HomeCare Corporation	$120.02	3.75%	0.00%	20.98	1.92	9.17%	7.13%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ADUS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Addus HomeCare

Addus HomeCare Corporation

Average Investor10 user rating

4.0 (1 people)

United States

20 years

Founded: 2006

2009

Time since IPO - 17 years

35.139

Employees

Addus HomeCare Corporation (United States) is listed on the Nasdaq and has a market capitalization of $2.21 billion, with shareholders equity totaling $1.15 billion.

The company employs approximately 35.139 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Addus HomeCare Corporation reported $1.48 billion in revenue, generating net income of $105.31 million.

Key financial metrics include a P/E ratio of 20.98, a price-to-book (P/B) ratio of 1.92, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ADUS.

Market cap

$2.21 billion

Net worth

$1.15 billion

$1,148,160,000.00

Assets

$1.46 billion

$1,456,490,000.00

Total Shares Outstanding

19.00 million

19,000,000

Average Daily Trading Volume

$244.11 Thousand

$244,108.00

Sector

Health

Industry

Health Services and Providers

ADUS

ADUS revenue and profits

Financial Results ADUS

DRAG THE FRAME TO SEE MORE DATA

ADUS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87